Company Overview
APG (Advanced Proteome Therapeutics Corporation) is a biotechnology company that specializes in developing cutting-edge therapies to fight cancer. The company was founded in 2014 and is headquartered in Vancouver, Canada.
Company History
APG was founded in 2014 by Dr. Randal Chase, a renowned biotech entrepreneur, and Dr. Wilfred Jefferies, a world-renowned immunologist. The company has since grown to become a leader in developing innovative cancer treatments using its proprietary proteomic technology.
Stock Symbol
APG is publicly traded on the Toronto Stock Exchange (TSX) under the symbol “APC”.
Website
The official website for APG is www.advancedproteome.com.
Company Revenue
APG is a pre-revenue company, meaning that it has not yet generated any revenue from its operations. However, the company has received funding from investors and has secured grants to support its research and development efforts.
Founders
The founders of APG are Dr. Randal Chase and Dr. Wilfred Jefferies. Dr. Chase has over 25 years of experience in the biotech industry, having founded and managed several successful biotech companies. Dr. Jefferies is a renowned immunologist with over 30 years of experience in the field.
Employee Count
As of 2021, APG has a team of 20 employees, including researchers, scientists, and business professionals.
Products and Services
APG is currently developing a portfolio of novel cancer therapies using its proprietary proteomic technology. This technology allows the company to identify and target specific proteins that are involved in cancer growth and progression.
The company’s lead product candidate is APG-157, a novel protein therapeutic that targets cancer stem cells, which are known to be resistant to traditional cancer treatments. APG-157 has shown promising results in preclinical studies and is currently in the process of being evaluated in clinical trials.
APG is also developing other protein therapeutics, including APG-115, which targets the MDM2 protein, and APG-138, which targets the GPR56 protein.
Contact Information
APG’s headquarters are located at 6190 Agronomy Rd, Vancouver, BC V6T 1Z3, Canada. The company can be reached by phone at (604) 229-1058 or by email at [email protected].
Sources
Information for this article was obtained from the APG website, press releases, and reputable news sources such as PR Newswire and Yahoo Finance.
Source : Google
Editor by : Softwarehubs